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Knowledge Transfer Statement 
The results of this study are relevant because they will allow clinicians to consider the use of 
brief and easy-to-administer self-report measures to identify POFP patients at higher risk of 
poor outcome so that management can be planned accordingly. 
 
Abstract 
INTRODUCTION: Persistent orofacial pain (POFP) can be caused by a range of conditions 
affecting the mouth and face and is often associated with significant disability. 
Biopsychosocial factors are known to be important predictors and have not yet been fully 
explored in this population. 
OBJECTIVES: This study aimed to explore whether Illness perceptions and psychological 
distress (anxiety and depression) could predict long-term outcome in a community based 
sample of patients receiving routine care for persistent orofacial pain (POFP).  
METHODS: A longitudinal cohort design study assessed 198 patients recruited from primary 
or secondary healthcare settings on 5 separate occasions over a 2 year period. Outcome 
was measured by the Graded Chronic Pain Scale and dichotomised into good or poor 
outcome categories. Independent variables included subscale scores of the psychometrically 
shortened Illness Perception Questionnaire (IPQ-PR) and the Patient Health Questionnaire-
4 (PHQ-4, assessing anxiety and depressive symptomatology). Logistic regressions were 
performed to test whether scores on each subscale would be associated with different 
outcome for patients at 12 and 24 months and overall. 
RESULTS: Beliefs about Consequences predicted outcome category (good vs poor) above 
and beyond other illness perception subscales, anxiety and depressive symptomatology 
(z=3.78, p<0.000, OR 3.05 95%CI 1.71 – 5.43). Both depressive symptomatology, measured 
by the PHQ-2 (p=.001 OR 4.06 95%CI 1.74 – 9.52) and psychological distress (mixed 
anxiety and depression, p=.029 OR 2.88 95%CI 1.12 – 7.41) measured by the PHQ-4 were 
also predictive of poor outcome, however these effects were no longer significant once 
measures of Illness perceptions were added. 
CONCLUSION: Beliefs about the consequences of POFP are important predictors of 
outcome independent of other variables and can easily and briefly be included in 
assessments to inform management decisions. 
  
Introduction 
Persistent Orofacial Pain (POFP) refers to a range of pain conditions of a non-dental 
aetiology in the region of the face and mouth (Beecroft et al. 2013). POFP can be difficult to 
diagnose and manage and may have a considerable impact on quality of life (Shueb et al. 
2015). 
POFP is known to be biopsychosocial in nature (Dworkin 1994), influenced by a broad range 
of both psychosocial and physiological factors. Increased somatization (now classified by 
DSM-5 as somatic symptom disorder (APA 2013)), depression (Liao et al. 2011; Velly et al. 
2011; Nevalainen et al. 2017) and health anxiety (Aggarwal et al. 2010) have been found to 
increase the risk of developing POFP and to predict poor outcome once pain is present 
(Galli et al. 2010; Velly et al. 2011). These findings mirror those in a wide range of persistent 
pain (Pincus et al. 2002) and other long-term conditions which are the basis of English 
government recommendations for psychological treatments for long-term conditions 
(National Collaborating Centre for Mental Health 2018). 
An important question that remains is how we might draw on our knowledge of the 
relationships between these factors to develop, target and deliver appropriate management 
strategies. Referral to psychology services is recommended for patients with comorbid 
depression or anxiety (National Collaborating Centre for Mental Health 2018) but it can be 
difficult to collect relevant information to aid referral decisions within the short space of time 
available clinically. It is also difficult to use diagnoses of depression, anxiety or somatic 
symptom disorder to plan specific management strategies as such diagnoses cover a broad 
range of symptoms. While they provide information about a possible poor prognosis, a 
detailed understanding of mechanisms behind this effect may enable more effective 
targeting of treatment strategies.  
Specific psychological constructs that may be associated with poor outcome in POFP 
conditions include catastrophization, self-efficacy and somatization (Velly et al. 2011) (Litt et 
al. 2010; Litt and Porto 2013). Illness representations have also been found to be important. 
A study (Galli et al. 2010) identified beliefs about the consequences of pain as an important 
predictor of outcome after 3 months of treatment, with beliefs about low personal control and 
a chronic timeline also accounting for some of the variation in outcomes. This is important 
because when illness beliefs can be readily addressed there is evidence that even a single 
session may lead to improved outcomes (Bonathan et al. 2014). Galli et al, however, 
reported outcomes only up to 6 months and within the context of a specialist Orofacial Pain 
Service where participants received individualised therapy according to their assessed 
needs. It is not known whether beliefs about illness at baseline would also be relevant within 
a community sample receiving non-specialist treatment over a longer period of time.  
The primary aim of this study was to examine whether illness beliefs would predict outcome 
in a POFP cohort receiving routine treatment in the North of England over a period of 2 
years. Secondary aims were to explore the ability of the Patient Health Questionnaire-4 
(PHQ-4) which measures anxiety and depression and the Patient Health Questionnaire-2 
(PHQ-2) which measures depression to screen for psychological comorbidity which may 
warrant further exploration and referral to specialist services. This was part of a larger study 
which tracked patient care pathways and costs associated with POFP over a 2 year period 
(Durham et al. 2016). 
Methods 
A closed cohort design longitudinal study was used to follow 198 patients receiving routine 
care for POFP in primary or secondary healthcare settings. A series of logistic regressions 
were carried out to assess the relative contribution of attributes measured by a number of 
self-report measures to long-term outcome of POFP.  
Methodology used in this study is consistent with STROBE (Strengthening the Reporting of 
Observational Studies in Epidemiology) guidelines for a human observational study. The 
study providing the data for this manuscript was reviewed and approved by a U.K. research 
ethics committee (NRES Reference: 12/YH/0338).  
Sample and data collection 
The sample consisted of patients who had experienced musculoskeletal, neuropathic, or 
neurovascular POFP for 3 months or more. Ethical guidelines were followed and all patients 
gave written, informed consent to participate in the study.  
Full details of recruitment and data collection procedures are described elsewhere (Durham 
et al. 2014; Durham et al. 2016; Breckons et al. 2018) and are available with open access at 
eprint.ncl.ac.uk. Further information is also included in the supplementary appendix. Briefly, 
a power calculation was carried out based on an empirical decision aimed at ensuring it was 
possible to detect a difference in the Graded Chronic Pain Scale between those receiving 
treatment in primary and those in secondary care at a moderate effect size of 0.4 (Cohen 
1992) and type 1 and 2 errors of 5% and 20% respectively (α=0.05, β=0.2). The calculation 
indicated a total sample size of 200 would be required. This sample size also served the 
need to be able to identify significant predictors of pain-related disability according to 
accepted practice (Green 1991). The initial aim was to recruit 240 participants in order to 
allow for an estimated dropout rate of 20%. Data for this study consisted of the responses of 
198 patients who completed baseline measures.  
Primary Outcome Measure 
The primary outcome measure for this study was the Graded Chronic Pain Scale (GCPS) 
(Von Korff et al. 1992). The GCPS is a measure of characteristic pain and disability widely 
used in this population. Pain intensity and disability are each measured by taking an average 
of three questions with scores ranging from 0 to 10. These scores are then combined with 
the number of days patients report being prevented from their usual activities in the last six 
months. At each of the five data collection timepoints (baseline, 6 months, 12 months, 18 
months and 24 months) GCPS scores were dichotomised into ‘low’ GCPS (GCPS grades 0, 
1 or 2a) or ‘high’ GCPS (GCPS grades 2b, 3 or 4) states following the method described by 
Dworkin and colleagues (Dworkin et al. 2002). Based on the rationale that POFP are long-
term conditions which tend to vary over time, outcomes were further collapsed into a single 
outcome measure (‘overall GCPS outcome over time’), according to the mode GCPS state 
over time for each participant. Thus, each participant with complete GCPS data was 
allocated to one of two groups: overall GCPS ‘good outcome over time’ (low GCPS state on 
at least 3 of the 5 study timepoints), or overall GCPS ‘poor outcome over time’ (high GCPS 
state on at least 3 of the 5 study timepoints). 
Other Measures 
The PHQ-4, an ultra-brief screening tool (Kroenke et al. 2009) screens for depression and 
anxiety by combining the PHQ-2 (for depression) with the Generalized Anxiety Disorder 
scale (GAD-2), an ultra-brief anxiety screener (Kroenke et al. 2007). Each scale includes two 
questions with responses on a four point scale ranging from ‘not at all’ to ‘nearly every day’. 
The scales show good reliability, with Cronbach’s alpha for this sample of 0.89 (PHQ-4) and 
0.89 (PHQ-2). At each point in time, depression was coded as present (PHQ-2 score of 3 or 
above) or absent (PHQ-2 score of 2 or below). For comparison, the total PHQ-4 score was 
also calculated and collapsed into two categories (PHQ-4 score of 6 or above indicating 
psychological distress). This corresponds to the recommended cut off point for detecting 
moderate depression and anxiety (Löwe et al. 2010).  
The Illness Perceptions Questionnaire-Psychometrically Shortened (IPQ-PS) (Sniehotta et 
al. 2010) is a shortened version of the Illness Perceptions Questionnaire-Revised (IPQ-R) 
(Moss-Morris et al. 2002) developed by using the three items for each IPQ-R subscale which 
demonstrated the highest factor loadings in the original study (Moss-Morris et al. 2002). The 
scale consists of 21 items across 7 domains (listed with Cronbach’s alpha for this sample): 
Timeline (0.88), Consequences (0.82), Personal Control (0.60), Treatment Control (0.75), 
Illness Coherence (0.47) and Emotional Representations (0.84). A list of questions included 
is shown in Table S1. Each question is scored on a 5 point scale ranging from strongly 
disagree to strongly agree. Means and standard deviations of the independent variables 
used in the study at baseline are summarised in Table 2. 
Data Analysis 
A standardised protocol was followed for nonresponse which is reported in the 
supplementary appendix. Data were analysed using STATA software (version 15; 
StataCorp-LP). Baseline study variables were correlated with dropout status throughout the 
study. Variables that correlated significantly (p<0.05) with dropout were entered with 
demographic variables into a logistic regression equation with dropout status as the 
independent variable.  
Due to the non-normal distribution of much of the data non-parametric tests were chosen to 
analyse changes over time. Spearman correlations were calculated of Overall dGCPS over 
time with Illness Perception and PHQ variables (tables S3-5). With the exception of the PHQ 
scales which include overlapping items and were entered into separate equations, all 
correlations were under 0.75 indicating no collinearity between measures. Illness 
perceptions which correlated with Overall dGCPS over time (p<0.05) were selected as 
independent variables, along with depression. Correlations showed consistency over time, 
with Timeline, Consequences and Emotional Representations significantly correlating with 
the overall outcome measure at 0, 12 and 24 months. Therefore Timeline, Consequences 
and Emotional Representations were selected along with depression to be entered in the 
logistic regression equations. 
A series of logistic regressions were then undertaken. Scores on the PHQ-2 (score≥3) and 
PHQ-4 (score≥6) were used to create the dichotomous variables ‘depressed’ and 
‘psychologically distressed’. These were entered as variables into separate logistic 
regression equations to test their relative ability to predict outcome status (using the GCPS 
measure described above). controlled by demographic factors (age, gender, deprivation 
index (Government 2015), time since onset, diagnosis category, education level and work 
status). Deprivation index was derived from English government rankings of relative 
deprivation by neighbourhood (low ranks indicate higher deprivation). 
 
Multiple logistic regression analyses were then carried out of the three Illness Perception 
subscales that correlated significantly with overall outcome, depression and the 7 
demographic variables against the dependent variable overall GCPS outcome over time. 
 
Results 
Demographics of the study sample are shown in Table 1. The sample represented 
participants across the adult age range and from a range of social backgrounds. Females 
outnumbered males by a ratio of approximately 4:1. Figure 1 demonstrates recruitment and 
attrition at the key time points of this study.  
  
Just over one-third (34.33%) of participants dropped out of the study over 2 years. Dropout 
was not significantly associated with any of the baseline study variables, GCPS outcome 
category or with social class, gender, duration of pain, diagnosis, employment status or 
education level. However, younger participants were more likely to drop out of the study 
(Z=2.11, p=0.035, OR=2.36 95%CI=1.06-5.23). Participants with lower initial pain scores 
measured by the characteristic pain intensity subscale (CPI) of the GCPS were also 
marginally more likely to drop out before the end of the study (Z=-2.09, p=0.036, OR=0.981 
95%CI=0.96-0.99). Despite patients who reported initially lower levels of pain being more 
likely to drop out, results of successive Wilcoxon Signed Rank tests indicated that CPI 
scores reduced from baseline at 12 and 24 months with significant improvements at 12 
months from baseline (Z=6.512, p<.000 and at 24 months from 12 months (Z=2.598, p<.010 
and from baseline (Z=6.745, p<.000). 
Means and standard deviations of illness perception and mood scores at baseline are shown 
in table 2. Wilcoxon signed-ranks tests indicated that consequences and emotional 
representations differed significantly between high and low GCPS disability groups at all 
timepoints and timeline representations differed at 12 and 24 months (table S7). Patients 
who endorsed more consequences, and higher emotional impact were more likely to be in 
the high disability group as defined by dGCPS at all points in time. At 12 and 24 months 
patients with high disability also viewed pain as more likely to be permanent and as difficult 
to comprehend. At 24 months patients in the high disability group also reported lower levels 
of personal control. Other illness perceptions did not differ significantly by group. 
Results of the single-factor logistic regressions of PHQ-2 and PHQ-4 against GCPS 
outcome are shown in Table 3. Both variables predicted significantly higher odds of a poor 
outcome at baseline (depression OR 4.06, psychological distress OR 3.81), 12 months 
(depression OR 2.94, psychological distress OR 3.81) and 24 months later (depression OR 
4.91, psychological distress OR 2.13), as well as on overall GCPS outcome over time 
(depression OR 3.40, psychological distress OR 4.18). However, neither depression nor 
psychological distress remained significant when added to multifactorial models along with 
Illness perception variables (Table 3). 
Results of controlled multiple logistic regressions are shown in table 4. Consequences 
(z=3.78, p<0.000, OR 3.05 95%CI 1.71 – 5.43) IMD dichotomised social deprivation 
classification representing higher SES (z=-2.06, p=0.039, OR 0.42 95%CI 0.18-0.96) and 
age (z=-2.64, p=0.01, OR 0.95 95%CI 0.91 – 0.99) were significant predictors of overall 
GCPS outcome in a model that accounted for 25% of outcome variance. 
At 12 months only Consequences (z=3.31, p=0.001, OR 3.38, 95%CI 1.64 – 6.93) and at 24 
months Consequences (z=2.70, p=0.007 OR 4.09 95%CI 1.47–11.35) and age (z=-2.19, 
p=0.028 OR 0.93 95%CI 0.87–0.99) were the only significant variables related to poor 
outcome.  
Discussion 
The primary purpose of this study was to examine the contribution of Illness Perceptions to a 
GCPS overall outcome measure representing high or low disability over a period of 2 years 
in a cohort of patients receiving routine care for POFP. We chose not to limit our definition of 
‘routine care’ as the intention of the study was to map current practice. Our sampling 
strategy deliberately included patients managed both within primary and secondary care; in 
practice many patients moved between primary and secondary care during the course of the 
study making separate analysis unrealistic. While the heterogeneity of treatment may have 
had an impact on study variables it also allowed us to sample a broad range of patients.  
Of the Illness Representations reported, only the ‘Consequences’ scale of the IPQ-PS was 
consistently linked to our measure of outcome independent of other measures. This is in 
keeping with previous research (Galli et al. 2010) which reported that baseline 
‘Consequences’ was the main significant predictor of outcome at 3 months in a similar 
population receiving specialist care. 
These findings suggest that ‘Consequences’ beliefs could be the target of psychosocial 
interventions. Galli and colleagues (Galli et al. 2010) found that by 6 months Consequences 
beliefs were no longer predictive of outcome. It would be interesting to explore whether or 
not this change could have been related to the targeted multidisciplinary treatment reported 
in this study. In our sample negative perceptions of the consequences of the condition 
remained significantly more prevalent in people with poor outcome at 12 and 24 months and 
overall. It is highly unlikely that these patients accessed multidisciplinary treatment as 
specialist psychology and physiotherapy input for POFP was not available locally at the time 
of the study. 
Younger age was also associated with poor outcome at 2 of the 3 data collection points, 
baseline and 24 months. Due to limitations discussed below it is important to be cautious 
about this result, however the finding does indicate that age may be relevant and should be 
explored further. If younger age is indeed linked with poorer outcomes this could be related 
to pain being more disruptive of the demands typically placed on younger people. 
Alternatively there could be risk factors for the development and persistence of pain which 
are stronger in the younger patients thus leading to the manifestation of pain at an earlier 
age. Given methodological limitations the one finding, at baseline that the index of multiple 
deprivation was also linked to overall outcome may be a chance occurrence. 
In keeping with other studies (Liao et al. 2011; Velly et al. 2011; Nevalainen et al. 2017) 
depression was a risk factor for poor outcome in POFP. However, this effect no longer held 
in a controlled model including other study variables. Similar results have been reported in 
previous research (Velly et al. 2011) in which the significant association between depression 
and treatment outcome disappeared when catastrophizing was added to the model; in the 
current study adding a measure of consequences beliefs had the same effect. While 
depression is important in POFP and other chronic conditions this result underlines the 
importance of assessing and working with depression in context. A thorough formulation of 
factors which are instrumental in maintaining depression, leading to a specific treatment 
plan, is important as standardised generic treatments for depression may miss important 
individual differences or factors specific to POFP or more broadly to chronic conditions. 
Given that perceptions of ‘Consequences’ do seem to be important it is worth looking further 
at what this scale measures. The version of the scale used in this study includes three 
questions: 
 My pain has major consequences on my life 
 My pain causes difficulties for those who are close to me 
 My pain strongly affects the way others see me. 
These questions largely refer to beliefs about the impact of pain in the social domain. This 
domain of the biopsychosocial model is the least well researched in relation to pain 
management, although there is evidence that physical and social pain may share the same 
pathways (Eisenberger and Lieberman 2004). Social factors precipitated by pain may 
include changes in relationships caused by factors such as misunderstanding, shame and 
stigma (Karos et al. 2018). This is consistent with descriptions given by patients of the 
impact of their POFP (Durham et al. 2010). The ‘Consequences’ scale used in this study 
may be capturing participants’ understanding of their experience in this domain.  
It seems important that a biopsychosocial assessment of POFP should include an 
assessment of Consequences beliefs. The relevance of these beliefs in our study seems to 
support the assertion (Karos et al. 2018) that routine assessment should include ‘standard 
assessment of interpersonal needs and motivations’ and that treatment should aim to 
recognise and address these as far as possible. In terms of psychosocially focused 
treatments such as cognitive behavioural therapy (CBT) and self-management a 
comprehensive assessment and formulation may help to determine which treatment 
approaches are most likely to be of help. While traditional CBT interventions can be good for 
targeting erroneous beliefs, thoughts about the social impact of pain are likely to include an 
element of truth and it would be difficult to assess their accuracy. Third-wave CBT 
interventions such as Acceptance and Commitment Therapy (Hayes and Wilson 1994; 
McCracken et al. 2004), or Compassion Focused Therapy (Gilbert 2009; Penlington 2018), 
may be better placed to target these beliefs and related behaviours.  
The secondary aim of this study was to test the relevance of the PHQ-4 and the PHQ-2 in 
this population. Scores above the recommended clinical cut off on both measures (Löwe et 
al. 2010) were associated with significantly increased odds of poor outcome. These odds 
were no longer significant when Illness perceptions were added into the models, indicating 
that there may be some shared variance between the constructs measured by the 
instruments (PHQ-2 and-4 and IPQ-PS).  
Depression has been identified as a risk factor for onset or poor outcome in POFP in a 
number of previous prospective studies using well-validated more extensive instruments 
resulting in odds ratios varying between 1.67 and 2.5 (Liao et al. 2011; Velly et al. 2011; 
Nevalainen et al. 2017). The odds ratios in the current study of between 2.94 and 4.06 
related to the PHQ-2 and PHQ-4 dichotomised measures seem to be largely consistent with 
these studies. However, these findings are limited by wide confidence intervals and the lack 
of an equivalent but more extensive measure against which they could be validated. While 
further research is needed, this study supports the use of the PHQ-4 as a useful screening 
measure in POFP with a cut off score of 6, in line with similar findings in other populations 
(Kroenke et al. 2009; Löwe et al. 2010). 
There are some limitations to this study which include the dropout rate of 34% over the two 
years of the study. This may limit the findings, particularly with regard to younger patients 
and those who had lower levels of pain who were more likely to drop out. In terms of other 
variables the lack of significant differences at baseline between those who stayed in the 
study or dropped out suggest that any bias caused by study dropout may be limited.  
The drop-out rate may also affect the logistic regression where the limitation of sample size 
is the smaller of the two outcome groups (Babyak 2004). In this study this was n=77 at 
baseline, reducing to n=35 at 24 months, suggesting that results might be artificially inflated 
in equations including more than 3 variables. This said the selection of Consequences 
Beliefs  was a priori based on previous research and this and the consistency of its 
relationship with a poor outcome over time (both single and multiple factor models) 
strengthens the possibility that this is a true finding. Other findings reported which occur less 
consistently must be treated with a greater degree of caution and be subject to further 
research which takes into account the likelihood of a high degree of attrition and an uneven 
allocation between outcome categories. 
The allocation of patients, over a period of two years and five separate data collection points, 
to a single outcome category required some compromises to be made. Overall outcome was 
defined as the mode outcome over the 2 year period, ie 3 or more data points at which a 
‘high’ or ‘low’ disability GCPS score was collected. The rationale for this was that POFP is a 
long term condition which naturally fluctuates and that a composite measure over time was 
therefore most likely to be a more accurate representation of long term outcome. This 
method cannot, however, detect changes over time that may be associated with treatment or 
other factors. For the variables considered in this study the consistency of findings reported 
using the dGCPS measure at baseline, 12 and 24 months and those using the overall 
outcome measure suggest that, despite the limitations of the overall outcome measure the 
findings remain robust.  
The lack of inclusion of a questionnaire which has been validated in this population 
specifically for depression against which to compare the PHQ-4 weakened our ability to 
thoroughly test the utility of this measure. It would be beneficial for future research to include 
a well validated depression questionnaire such as the Patient Health Questionnaire-9 (PHQ-
9) for a more robust exploration of the performance of the PHQ-4. 
Strengths of the study, however, include the longitudinal timeframe of 2 years which allowed 
for data to be collected on at least 3 (and for some measures 5) separate occasions. The 
main results reported remained consistent across more than one point in time which adds 
confidence to the findings. The broad recruitment strategy which included a range of patients 
with POFP across both primary and secondary care settings also adds strength to the 
generalizability of our findings. 
 
Conclusion 
This study has demonstrated that patients’ perceptions of the Consequences of their POFP 
are important in a community sample of people receiving routine care but that other Illness 
Perceptions may be of little predictive value. It has also provided some initial support for the 
use of the PHQ-4, an easy to administer questionnaire consisting of just four questions to 
screen for depression and anxiety in this population. 
While it has previously been suggested that the GCPS can be used to target the appropriate 
level of care for patients (Durham et al. 2016), the addition of a brief assessment of key 
biopsychosocial measures may also help with targeted treatment. This could be used to 
triage patients who may benefit from a supported psychological or self-management 
intervention alongside their dental care. In the related area of back pain a brief questionnaire 
consisting of only 9 items has been successful in targeting treatment, reducing costs and 
improving outcomes (Hill et al. 2011). Further work would be helpful to explore whether a 
similar approach could be successful for orofacial pain management. 
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Table 1: Demographic variables at baseline  
Variable n Male Female Total 
Years in pain: 
<1 year 2 25 27 
1 – 5 years 12 70 82 
>5 years 24 65 89 
Origin of pain 
Musculoskeletal 18 68 86 
Neuropathic/vascular 11 53 64 
Combined 9 39 48 
Deprivation index* 
Bottom 50% 21 60 81 
Top 50% 17 97 114 
Employment 
Employed 12 77 89 
Retired 18 52 70 
Other 7 29 36 
Age 
20 – 39 5 41 46 
40 – 59 13 64 77 
60+ 20 52 72 
GCPS grade    
0 0 3 3 
1 12 49 61 
2a 12 45 57 
2b 5 30 35 
3 5 26 31 
4 4 7 11 
GCPS category    
Low 24 97 121 
High 14 63 77 
Breakdown of demographic information by gender for full study sample (n=198). 
*Deprivation index refers to classification of home neighbourhood by the English Index of 
Multiple Deprivation (IMD) (1) into deciles of deprivation which are then further collapsed into 
categories of high deprivation and low deprivation. 
  
Table 2: Mean (SD) self-report scores on illness perceptions and mood at baseline by 
gender 
 Male Female Overall 
Timeline 3.79 (0.92) 3.61 (0.85) 3.64 (0.86) 
Consequences 3.18 (1.22) 2.91 (1.03) 2.96 (1.07) 
Personal Control 2.80 (0.90) 3.06 (0.79) 3.01 (0.82) 
Treatment Control 2.99 (0.80) 3.08 (0.85) 3.06 (0.84) 
Cyclical Timeline 3.78 (0.74) 3.49 (0.96) 3.55 (0.93) 
Illness Coherence 3.09 (1.06) 3.27 (1.16) 3.23 (1.14) 
Emotional 
Representations 
3.28 (1.15) 3.20 (1.10) 3.22 (1.10) 
PHQ4 3.97 (3.51) 3.36 (3.48) 3.48 (3.48) 
PHQ2 2.16 (2.12) 1.5 (1.81) 1.63 (1.89) 
GAD2 1.82 (1.71) 1.84 (1.99) 1.83 (1.94) 
Illness perceptions include 7 subscales of the IPQ-PR as shown. PHQ2 (depression) and 
GAD2 (anxiety) scales combine to form the PHQ4. Means and standard deviations reported 
for the full sample (n=198) and separately for males (n=38) and females (n=160). Mann-
Whitney tests indicated no significant differences between males and females on any of the 
above scales. 
 
Table 3: Logistic regression of PHQ-2 and PHQ-4 at baseline as predictors of poor 
outcome over time. 
 PHQ-2 PHQ-4 
 OR 95% CI p OR 95% CI p  
Baseline 4.06 1.74 – 9.52 .001 2.88 1.12 – 7.41 .029 
12 months 2.94 1.03 – 8.42 .044 3.81 1.15 – 12.58 .028 
24 months 4.91 1.33 – 18.19 .017 2.13 0.52 – 8.69 .294 
Overall 3.40 1.41 – 8.17 .006 4.18 1.50 – 11.67 .006 
Results of single-factor logistic regressions controlled for demographic factors (age, gender, 
deprivation index, time since onset, diagnosis category, education level and work status) 
  
Table 4: Collated results of three logistic regressions showing odds ratios of baseline 
variables† regressed against dGCPS over time 
 Odds ratio of overall good outcome over time (dGCPS)‡ 
Independent variable at 
baseline (M0) † 
Baseline 
 
(n=167 obs.) 
12 months 
 
(n=131 obs.) 
24 months 
 
(n=104 obs.) 
OR p OR p OR p 
Timeline 0.907 0.727 0.972 0.933 1.507 0.315 
(95% Confidence Intervals) 0.521 – 1.578 0.504 – 1.873 0.677 – 3.354 
Consequences 3.048 0.000** 3.376 0.001** 4.086 0.007** 
(95% Confidence Intervals) 1.710 – 5.431 1.643 – 6.933 1.471 – 11.348 
Emotional 
Representations 
0.771 0.291 1.037 0.919 2.091 0.159 
(95% Confidence Intervals) 0.475 – 1.249 0.517 – 2.077 0.750 – 5.829 
PHQ-2 1.384 0.533 2.063 0.271 0.572 0.547 
(95% Confidence Intervals) 0.499 – 3.837 0.568 – 7.488 0.0993 – 3.519 
Index of multiple 
deprivation (IMD) 
0.417 0.039* 0.802 0.689 0.342 0.132 
(95% Confidence Intervals) 0.182 – 0.958 0.271 – 2.368 0.085 – 1.384 
Age 0.951 0.008** 0.959 0.088 0.930 0.028* 
(95% Confidence Intervals) 0.917 – 0.987 0.914 – 1.006 0.871 – 0.992 
†Results of multiple logistic regression equations of variables which initially correlated at 
p<0.05 with dichotomised Graded Chronic Pain Scale d(GCPS) ‡ outcome measure at 12 
months, 24 months and overall.  
Significance is indicated by *(p<0.05) or **(p<0.01) 
‡dGCPS: M12 & M24 were low vs high dGCPS state; overall GCPS outcome was ‘poor’ if ≥3 
high states over time and ’good’ otherwise i.e. the mode state was taken across the five 
timepoints 
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Supplementary Methods 
Recruitment took place over a period of 22 months and included prospective and retrospective 
recruitment from primary care (non-specialist treatment) and prospective recruitment within 
secondary care (specialist treatment). For retrospective recruitment specific diagnostic codes 
referring to persistent orofacial pain were identified and patient records in primary care 
electronically searched for a match to one or more of these codes during the preceding 12 months. 
Patients identified using this method were contacted in writing and invited to make contact with the 
research team if they were interested in participating in the study. Patients recruited prospectively 
were approached by a member of staff, given a short description of the study and asked if they were 
interested in participating. All patients who expressed an interest in participating were given a study 
pack including an information sheet, initial consent form and a self-report screening measure. They 
were then contacted by telephone by the research team who completed the screening measure 
over the telephone. Those screening positive and giving informed consent were enrolled into the 
study. 
Once enrolled in the study following informed consent and a positive screening result 
structured interviews were then completed with a trained interviewer at baseline. Follow-up 
data was collected by post. Study questionnaires were mailed to participants at each study 
timepoint, and a period of 14 days allowed for their return. Patients with missing or 
incomplete data after this period were followed up by telephone to remind them to complete 
the questionnaires or clarify any missing or confusing data. 
Repeated measures Friedman’s two-way ANOVAs were performed on each of the 7 illness 
perceptions tested to monitor change over time. 
Supplementary Results 
A total of 387 individuals were referred for screening for eligibility for the study. Of these 12 
were from retrospective recruitment (3%). The majority (72%) of those referred accepted the 
invitation to be screened with two individuals from retrospective recruitment declining to be 
screened. There was no significant difference in gender (X
2
(1, n=386)=0.66; p=0.261), age 
(t(366)=1.24; p=0.215; 95%CI difference -1.52, 6.73years), recruitment (X
2
(1, n=386)=0.66; 
p=0.261), between those declining and accepting the invitation to be screened. There were a 
significantly greater number of declined invitations from those referred from primary care 
than those referred from secondary care (X
2
(1, n=386)=6.610; p=0.01). Figure 1 
demonstrates recruitment and attrition at the key time points of this study.  
 
Perceptions of consequences (Z=3.079, p<.01) and emotional representations Z=3.365, 
p<.01) scores changed over time, showing some improvement from baseline to 24 months 
(table S6). There was no significant change over time in perceptions of timeline, personal or 
treatment control, illness coherence or cyclical timeline. 
When entered as single factors, Consequences and Emotional representations consistently 
predicted dGCPS grouping at every point in time (data not shown). Since Consequences 
beliefs were consistently related to outcome, these were further explored with Spearman 
correlations. Correlations at baseline were carried out between Consequences beliefs, 
characteristic pain index, PHQ4, age, classification of pain, index of deprivation, education 
and employment status. The same correlations were repeated at 12 and 24 months (using 
baseline measures of age, classification of pain, index of deprivation, education and 
employment status as data on these measures were only collected once). Results are 
shown in table S8 Significant correlations were reported between Consequences beliefs and 
younger age, PHQ4 score, classification of pain, and being neither employed nor retired. 
Index of deprivation and employment status were not correlated with Consequences beliefs. 
The reported correlations of ‘Consequences’ beliefs with higher reported pain younger age, 
higher psychological distress, unemployment and reduced likelihood of a simple 
‘musculoskeletal’ diagnosis of pain may be relevant in terms of understanding the impact 
that POFP has in different circumstances on many aspects of somebody’s life.  
Supplementary Table 1 (S1): Illness Perceptions Questionnaire-Psychometrically 
Shortened (IPQ-PS) 
 Views about your pain Relevant Domain 
1 I don’t understand my pain Illness Coherence 
2 My pain will last for a long time Timeline 
3 I get depressed when I think about my pain Emotional 
Representations 
4 My pain has major consequences on my life Consequences 
5 My treatment will be effective in curing my pain Treatment Control 
6 Having this pain makes me feel anxious Emotional 
Representations 
7 Nothing I do will affect my pain Personal Control 
8 My pain doesn’t make any sense to me Illness Coherence 
9 The negative effects of my pain can be prevented by my 
treatment 
Treatment Control 
10 My pain is very unpredictable Timeline Cyclical 
11 My pain is a mystery to me Illness Coherence 
12 My pain is likely to be permanent rather than temporary Timeline 
13 My pain causes difficulties for those who are close to me Consequences 
14 I have the power to influence my pain Personal Control 
15 My symptoms come and go in cycles Timeline Cyclical 
16 My pain strongly affects the way others see me Consequences 
17 My treatment can control my pain Treatment Control 
18 I go through cycles in which my pain gets better and 
worse 
Timeline Cyclical 
19 When I think about my pain I get upset Emotional 
Representation 
20 I expect to have this pain for the rest of my life Timeline 
21 My actions will have no effect on the outcome of my pain Personal Control 
IPQ-PS scale which was used in the study to assess Illness Representations. Items are 
scored on a scale of 1 (strongly disagree) to 5 (strongly agree). 
  
Supplementary Table 2 (S2): Missing data for each measure at baseline, 12 and 24 
months. 
Measure Data collection timepoint 
 Baseline (n=198) 12 months (n=155) 24 months (n=129) 
GCPS* (%) 3 (1.49%) 3 (1.91%) 0 (0%) 
PHQ4** (%) 11 (5.47%) 7 (4.46%) 13 (9.42%) 
IPQ-PS** (%) 6 (2.99%) 8 (5.10%) 9 (6.52%) 
Table shows number of participants in study with missing data for each measure at each 
time of data collection. *GCPS data was also collected at 6 months (n=172, 1 missing 
(0.6%)) and 18 months (n=136, 2 missing (1.4%)). **PHQ4 and IPQ-PS data was collected 
at baseline, 12 and 24 months only.  
 
 
 
 
Supplementary Table 3 (S3): Correlations at Baseline between all measures. 
Table shows Spearman correlations at baseline between Overall dichotomised Graded Chronic Pain Scale over time outcome category 
(dGCPS) and Illness perceptions subscales and PHQ subscales at baseline. PHQ-4 includes items from PHQ-2 (these scales were never 
included together in the same equation). Significance: * indicates p<.05, **p<.01. Bottom row shows p values at baseline of correlations of each 
measure with the dGCPS dichotomised outcome measure. 
 
 
 
 
Time 
1 2 3 4 5 6 7 8 9 10 
Graded Chronic Pain 
Scale category (1) 
 
0.209** 0.333** -0.012 -0.123 -0.015 -0.032 0.181* 0.309** 0.235** 
timeline (2) 
 
  0.457** -0.206** -0.327** -0.097 -0.059 0.455 0.296** 0.272** 
consequences (3) 
 
   -0.165* -0.163* -0.204** 0.055 0.692** 0.431** 0.430** 
personal control (4) 
 
   0.3417** 0.404** 0.001 -0.342** -0.223** -0.160* 
illness coherence (5) 
 
    0.140 0.160* -0.159* -0.071 -0.044 
treatment control 
(6) 
 
     -0.48 -0.47 -0.198** -0.168* 
cyclical timeline (7) 
 
      0.007 -0.027 0.085 
emotional  
representations (8) 
 
       0.518** 0.518** 
PHQ-2 (9) 
 
        0.883** 
PHQ-4 (10) 
 
         
p 
 
  0.004 0.000 0.872 0.835 0.090 0.664 0.012 0.000 0.000 
Supplementary Table 4 (S4): Correlations at 12 months between all measures. 
Table shows Spearman correlations at 12 months between Overall dichotomised Graded Chronic Pain Scale over time outcome category 
(dGCPS) and Illness perceptions subscales and PHQ subscales at baseline. PHQ-4 includes items from PHQ-2 (these scales were never 
included together in the same equation). Significance: * indicates p<.05, **p<.01. Bottom row shows p values at baseline of correlations of each 
measure with the dGCPS dichotomised outcome measure. 
 
 
 
 
Time 
1 2 3 4 5 6 7 8 9 10 
Graded Chronic Pain 
Scale category (1) 
 
0.236** 0.479** 0.0725 -0.139 -0.074 -0.002 0.383** 0.357** 0.305** 
timeline (2) 
 
  0.385** -0.232** -0.145 -0.383**- -0.064 0.429** 0.425** 0.442** 
consequences (3) 
 
   -0.102 -0.401** -0.142 0.053 0.719** 0.466** 0.398** 
personal control (4) 
 
   0.376** 0.427** 0.029 -0.203* -0.100 -0.009 
illness coherence (5) 
 
    0.200* 0.130 -0.465** -0.224** -0.134 
treatment control 
(6) 
 
     0.130 -0.143 -0.227** -0.168* 
cyclical timeline (7) 
 
      0.007 -0.001 -0.046 
emotional  
representations (8) 
 
       0.522** 0.501** 
PHQ-2 (9) 
 
        0.882** 
PHQ-4 (10) 
 
         
p 
 
  0.004 0.000 0.378 0.368 0.091 0.981 0.000 0.000 0.000 
Supplementary Table 5 (S5): Correlations at Baseline between all measures. 
Table shows Spearman correlations at 24 months between Overall dichotomised Graded Chronic Pain Scale over time outcome category 
(dGCPS) and Illness perceptions subscales and PHQ subscales at baseline. PHQ-4 includes items from PHQ-2 (these scales were never 
included together in the same equation). Significance: * indicates p<.05, **p<.01. Bottom row shows p values at baseline of correlations of each 
measure with the dGCPS dichotomised outcome measure. 
 
 
Time 
1 2 3 4 5 6 7 8 9 10 
Graded Chronic Pain 
Scale category (1) 
 
0.342** 0.512** -0.134 -0.152 -0.106 -0.062 0.477** 0.463** 0.444** 
timeline (2) 
 
  0.380** -0.283** -0.134 -0.336** -0.010 0.324** 0.381** 0.368** 
consequences (3) 
 
   -0.291** -0.392** -0.119 0.099 0.722** 0.451** 0.411** 
personal control (4) 
 
   0.433** 0.338** 0.005 -0.350** -0.164 -0.133 
illness coherence (5) 
 
    0.201* 0.053 -0.333** -0.107 -0.113 
treatment control 
(6) 
 
     -0.073 -0.110 -0.184* -0.195* 
cyclical timeline (7) 
 
      0.007 -0.027 0.053 
emotional  
representations (8) 
 
       0.506** 0.482** 
PHQ-2 (9) 
 
        0.936** 
PHQ-4 (10) 
 
         
p 
 
  0.000 0.000 0.149 0.104 0.258 0.507 0.000 0.000 0.000 
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Supplementary Table 6 (S6): Changes over time in illness perceptions and 
characteristic pain index measured by Wilcoxon signed-rank test. 
 
** p<.01 
  
Illness perception Difference (Z) Baseline mean (SD) 24month mean (SD) 
Timeline 0.988 3.8 (±0.9) 3.7 (±1) 
Consequences 3.079** 3.0 (±1.1) 2.8 (±1.2) 
Personal Control -1.530 3.1 (±0.8) 3.2 (±0.9) 
Treatment Control 0.237 3.1 (±0.9) 3.0 (±1.0) 
Illness Coherence -2.043 3.3 (±1.2) 3.5 (±1.2) 
Cyclical Timeline 0.238 3.5 (±1.0) 3.6 (±0.9) 
Emotional 
Representations 
3.365** 3.3 (±1.1) 3.1 (±0.9) 
Characteristic pain 
intensity 
6.745** 55.3 (±22.0) 40.7 (±25.0) 
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Supplementary Table 7 (S7): Differences in illness perceptions by outcome category 
across time. 
 Table shows means (standard deviations) of Illness Perception scales at baseline, 12 
months and 24 months by dichotomised Graded Chronic Pain Scale (dGCPS) (Dworkin et 
al. 2002) indicating high or low disability at each point in time and significance of differences 
  Baseline 
Illness perceptions construct 
mean score (SD): 
Low GCPS 
(n=121)  
High GCPS 
(n=77)  
Total 
(n=198) 
Differenc
e (z) p 
Timeline 3.7(±0.8) 3.9(±1) 
3.8(±0.9
) -1.778 0.075 
Consequences 2.6(±1) 3.6(±1) 3(±1.1) -6.469 0.000** 
Personal Control 3(±0.9) 3.1(±0.8) 
3.1(±0.8
) -0.879 0.379 
Treatment control 3.3(±0.9) 2.9(±0.8) 
3.1(±0.9
) 1.404 0.160 
Illness coherence 3.3(±1.2) 3.1(±1.2) 
3.3(±1.2
) 0.624 0.533 
Timeline cyclical 3.5(±1) 3.6(±1) 3.5(±1) -0.542 0.588 
Emotional representations 3(±1.2) 3.8(±0.8) 
3.3(±1.1
) -4.300 0.000** 
  12 months 
  
Low GCPS 
(n=113) 
High GCPS 
(n=43) 
Total 
(n=156) 
Differenc
e (z) p 
Timeline 3.6(±0.9) 4.2(±0.7) 
3.8(±0.9
) -3.772 0.000** 
Consequences 2.5(±1) 4(±0.9) 3(±1.2) -6.815 0.000** 
Personal Control 3.2(±0.8) 3(±0.8) 
3.2(±0.8
) 1.541 0.123 
Treatment control 3.1(±0.8) 2.6(±0.7) 3(±0.8) 2.823 0.005** 
Illness coherence 3.6(±1.1) 2.9(±1.2) 
3.4(±1.2
) 3.608 0.000** 
Timeline cyclical 3.5(±0.9) 3.5(±0.9) 
3.5(±0.9
) 0.049 0.961 
Emotional representations 3(±1) 4(±0.9) 
3.3(±1.1
) -5.437 0.000** 
  24 months 
  
Low GCPS 
(n=96) 
High GCPS 
(n=35) 
Total 
(n=131) 
Differenc
e (z)  p  
Timeline 3.4(±1) 4.3(±0.7) 3.7(±1) -4.699 0.000** 
Consequences 2.3(±0.9) 3.8(±0.9) 
2.8(±1.2
) -6.398 0.000** 
Personal Control 3.3(±0.9) 2.9(±0.8) 
3.2(±0.9
) 2.582 0.010** 
Treatment control 3.1(±1) 2.9(±1) 3(±1) 1.576 0.115 
Illness coherence 3.6(±1.1) 3.1(±1.2) 
3.5(±1.2
) 3.608 0.000** 
Timeline cyclical 3.6(±0.9) 3.4(±0.8) 
3.6(±0.9
) 1.352 0.176 
Emotional representations 2.7(±1) 3.8(±0.9) 
3.1(±1.1
) -5.018 0.000** 
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between high and low disability groups. Wilcoxon signed-rank tests were used to test for 
difference between low and high GCPS outcome status for each variable and at each point 
in time at **p<.01. 
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Supplementary Table 8 (S8): Spearman correlations between Consequences, 
characteristic pain intensity, PHQ4 and demographic factors 
 Baseline 12 months 24 months 
Age  -0.182* -0.241** -0.309** 
Characteristic pain intensity 0.331** 0.436** 0.541** 
PHQ4 0.394** 0.405** 0.387** 
Male 0.062 0.021 0.015 
Musculoskeletal diagnosis -0.261** -0.285** -0.344** 
Neuropathic diagnosis 0.216** 0.159 0.218** 
Combined diagnosis 0.069 0.177* 0.177 
Employed -0.024 0.028 0.120 
Retired -0.137 -0.101 -0.185 
Not employed or retired 0.198* 0.095 0.086 
Table shows Spearman correlations between Consequences scores, characteristic pain 
intensity and PHQ4 scores reported at each time of data collection. Demographic factors 
were measured only at baseline so correlations including these factors used the baseline 
measures. No significant correlations were reported between Consequences and 
Deprivation Index or level of education (data not shown). 
Significant correlations are indicated by *(p<.05) and ** (p<.01).  
 
 
 
 
